Helicobacter Pylori Diagnostics Market by Technology and Geography - Forecast and Analysis 2021-2025

The helicobacter pylori diagnostics market share is expected to increase by USD 209.59 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.1%. This helicobacter pylori diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The helicobacter pylori diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group Plc, QIAGEN N.V., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc. among others. Furthermore, this report extensively covers helicobacter pylori diagnostics market segmentation by technology (immunoassays, molecular diagnostics, and POC) and geographic (North America, Europe, and APAC).

What will the Helicobacter Pylori Diagnostics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Helicobacter Pylori Diagnostics Market Size for the Forecast Period and Other Important Statistics

 

Helicobacter Pylori Diagnostics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The rising prevalence of disease is notably driving the helicobacter pylori diagnostics market growth, although factors such as competitive pricing pressure may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the helicobacter pylori diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Helicobacter Pylori Diagnostics Market Driver

One of the key factors driving the helicobacter pylori diagnostics market growth is the rising prevalence of disease. Helicobacter pylori is a Gram-negative bacteria that colonize in the stomach and is reported to be one of the common factors for peptic ulcer, primary gastric lymphoma, and gastric adenocarcinoma. It affects more than 50% of the global population. Poor hygiene standards, crowded households, and deficient sanitation are some of the causative factors for Helicobacter pylori infections. Helicobacter pylori infections result in gastritis, gastric ulcers, and duodenal ulcers. According to a study by the NIH, about 90%-100% of duodenal ulcers and about 70%-80% of gastric ulcers are caused by Helicobacter pylori infections. Also, the World Health Organization has reported Helicobacter pylori infection as a class I carcinogen for gastric cancer, as it is reported to be one of the major cancer-causing agents. The increasing prevalence of cancer cases is expected to drive the growth of the market in focus during the forecast period.

Key Helicobacter Pylori Diagnostics Market Trend

Outsourcing from hospitals to reference laboratories are the major trend influencing the helicobacter pylori diagnostics market growth. Value-based outsourcing is one of the major focuses of the market, where the laboratory tests are outsourced from hospitals to clinical reference laboratories. There are small hospitals, which do not have the basic infrastructure for clinical diagnosis. These hospitals outsource patients to clinical reference laboratories for diagnostic tests. In the past years, outsourcing facilities have contributed to the growing financial incentives for clinical diagnostic services. The market is moving from fee-for-service to value-based care models to shift lab services to the outsourcing diagnostic vendors. The shift from hospital outsourcing services to reference laboratories will be a major market driver globally during the forecast period. The virtual diagnostic service is another area of interest where outsourcing is taking place. This has been gaining attention from the hospitals.

Key Helicobacter Pylori Diagnostics Market Challenge

Competitive pricing pressure is one of the key challenges hindering the helicobacter pylori diagnostics market growth. Global vendors invest significantly in marketing, promotion, and improvement of their brand quality to gain profit margins. However, the intense competition in the market leads to a price war. This causes global vendors to lower the average selling price of their devices to compete with high volume and low-cost sales agreements. End-users also play an important role in increasing price wars. The rise in partnership between end-users and key vendors leads to price fluctuations in the market. The low or negligible reimbursement offered by the government impacts the detection of Helicobacter pylori infection. The capital equipment required for the procedures such as immunoassays, molecular and POC diagnosis is covered fully or partially by the various governments. For instance, the National Health Service (NHS) provides coverage for the set-up of diagnostic equipment. The numerous vendors operating in the market influence price war and impact the market growth moderately.

This helicobacter pylori diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global helicobacter pylori diagnostics market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the helicobacter pylori diagnostics market during the forecast period.

Who are the Major Helicobacter Pylori Diagnostics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Abbott Laboratories
• Becton, Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Cardinal Health Inc.
• F. Hoffmann-La Roche Ltd.
• Omega Diagnostics Group Plc
• QIAGEN N.V.
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.

 

This statistical study of the helicobacter pylori diagnostics market encompasses successful business strategies deployed by the key vendors. The helicobacter pylori diagnostics market is fragmented and the vendors are deploying growth strategies such as organic and inorganic strategies to compete in the market.

Product Insights and News

• Abbott Laboratories - It is a rapid membrane enzyme immunoassay which is used for the qualitative detection of H.pylori specific antigen in human fecal specimens.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The helicobacter pylori diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Helicobacter Pylori Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the helicobacter pylori diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Helicobacter Pylori Diagnostics Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for helicobacter pylori diagnostics in North America. Market growth in this region will be slower than the growth of the market in other regions.

The highest market share is attributed to the rising prevalence of peptic ulcer disease, stomach cancer, and gastritis in the region, coupled with the availability of improved diagnostics that help in the early detection of symptoms, thereby increasing patient pool seeking treatment. The market is growing due to the continuous efforts of vendors to develop a vaccination for Helicobacter pylori infection and the introduction of improved diagnostic techniques. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

North American countries were severely affected by the outbreak of COVID-19 in 2020. The rise in the incidence of COVID-19 across the region influenced governments to introduce emergency legislation, including restrictions on several operations, across industries. This led to the shutting down of several manufacturing units in 2020, including that of helicobacter pylori diagnostics, in North America. The increase in the number of COVID-19 cases across the region delayed elective medical procedures and treatment, including treatment of helicobacter pylori infection, to prevent the risk of contracting COVID-19. This further reduced the demand for new helicobacter pylori diagnostics from healthcare providers. All these factors hindered the growth of the helicobacter pylori diagnostics market in the region in 2020. However, the lifting of lockdowns increased the number of scheduled medical procedures and treatment, including the treatment for helicobacter pylori infection. This has raised the demand for helicobacter pylori diagnostics. Furthermore, the growth in the number of advanced healthcare facilities with high-quality medical devices is expected to charter a recovery path and stabilize the growth of the helicobacter pylori diagnostics market in the region during the forecast period.

What are the Revenue-generating Technology Segments in the Helicobacter Pylori Diagnostics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The helicobacter pylori diagnostics market share growth by the immunoassays will be significant during the forecast period. This segment is the highest contributor to the diagnostic laboratories segment and represents the greatest test volume compared with the other types of testing. The demand for immunoassays is lowering in the US and, to an extent, in European markets. China and India have a growing rural hospital market that lacks basic diagnostics laboratory infrastructure representing a growth opportunity for affordable immunoassays.

Besides the above-mentioned factors, the post COVID-19 impact has brought forth a slowdown in or fast tracked the demand for the service or product. This report provides an accurate prediction of the contribution of all the segments to the growth of the helicobacter pylori diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

 

Helicobacter Pylori Diagnostics Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 8.1%
Market growth 2021-2025	$ 209.59 million
Market structure	Fragmented
YoY growth (%)	8.00
Regional analysis	North America, Europe, and APAC
Performing market contribution	North America at 39%
Key consumer countries	US, UK, Germany, Canada, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group Plc, QIAGEN N.V., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Helicobacter Pylori Diagnostics Market Report?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive helicobacter pylori diagnostics market growth during the next five years
• Precise estimation of the helicobacter pylori diagnostics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the helicobacter pylori diagnostics industry across North America, Europe, and APAC
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of helicobacter pylori diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch